期刊
NUCLEIC ACIDS RESEARCH
卷 45, 期 10, 页码 6023-6036出版社
OXFORD UNIV PRESS
DOI: 10.1093/nar/gkx135
关键词
-
资金
- Moderna Therapeutics
- Canadian Institute of Health Research (CIHR) [MOP-7214]
Certain chemical modifications confer increased stability and low immunogenicity to in vitro transcribed mRNAs, thereby facilitating expression of therapeutically important proteins. Here, we demonstrate that N1-methyl-pseudouridine (N1m Psi) outperforms several other nucleoside modifications and their combinations in terms of translation capacity. Through extensive analysis of various modified transcripts in cell-free translation systems, we deconvolute the different components of the effect on protein expression independent of mRNA stability mechanisms. We show that in addition to turning off the immune/eIF2 alpha phosphorylation-dependent inhibition of translation, the incorporated N1m Psi nucleotides dramatically alter the dynamics of the translation process by increasing ribosome pausing and density on the mRNA. Our results indicate that the increased ribosome loading of modified mRNAs renders them more permissive for initiation by favoring either ribosome recycling on the same mRNA or de novo ribosome recruitment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据